The Composition, Cell Interaction Patterns and Prognostic Impact of the Tumor Microenvironment in Germinal Center B-Cell and Activated B-Cell-like Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Autio, Matias [1 ,2 ]
Leivonen, Suvi-Katri [1 ,2 ]
Bruck, Oscar [3 ,4 ]
Karjalainen-Lindsberg, Marja-Liisa [5 ]
Pellinen, Teijo [6 ]
Leppa, Sirpa [1 ,2 ]
机构：
[1] Helsinki Univ Hosp, Dept Oncol, Comprehens Canc Ctr, Helsinki, Finland
[2] Univ Helsinki, Fac Med, Res Programs Unit, Appl Tumor Genom, Helsinki, Finland
[3] Univ Helsinki, Hematoscope Lab, Hosp Comprehens Canc Ctr, Helsinki, Finland
[4] Helsinki Univ Hosp, Dept Hematol, Comprehens Canc Ctr, Helsinki, Finland
[5] Helsinki Univ Hosp, Helsinki, Finland
[6] Inst Mol Med Finland, Helsinki, Finland
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158431
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3568 / 3569
页数：2
相关论文
共 50 条
  • [1] NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
    Odqvist, Lina
    Montes-Moreno, Santiago
    Sanchez-Pacheco, Roxana E.
    Youn, Ken H.
    Martin-Sanchez, Esperanza
    Cereceda, Laura
    Sanchez-Verde, Lydia
    Pajares, Raquel
    Mollejo, Manuela
    Fresno, Manuel F.
    Mazorra, Francisco
    Ruiz-Marcellan, Carmen
    Sanchez-Beato, Margarita
    Pins, Miguel A.
    MODERN PATHOLOGY, 2014, 27 (10) : 1331 - 1337
  • [2] Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype
    Sun, Jian
    Zhang, Jing
    Ling, Qing
    Luo, Yufeng
    Wu, Shafei
    Liang, Zhiyong
    Zhong, Dingrong
    Zeng, Xuan
    VIRCHOWS ARCHIV, 2015, 466 (01) : 93 - 100
  • [3] Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype
    Jian Sun
    Jing Zhang
    Qing Ling
    Yufeng Luo
    Shafei Wu
    Zhiyong Liang
    Dingrong Zhong
    Xuan Zeng
    Virchows Archiv, 2015, 466 : 93 - 100
  • [4] A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
    Cen, Hong
    Tan, Xiaohong
    Guo, Baoping
    PLOS ONE, 2015, 10 (12):
  • [5] Primary cardiac diffuse large B-cell lymphoma with activated B-cell-like phenotype
    Gadage, Vijaya
    Kembhavi, Seema
    Kumar, Prabhash
    Shet, Tanuja
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (03) : 591 - 593
  • [6] Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid
    Bin Waqar, Syed Hamza
    Khan, Anosh Aslam
    Guzman, Juan Coca
    Gottesman, Susan R. S.
    McFarlane, Isabel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [7] Prognostic impact of germinal center B-cell-like and non-germinal center B-cell-like subtypes of bone marrow involvement in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Cho, Min-Chul
    Chung, Yousun
    Jang, Seongsoo
    Park, Chan-Jeoung
    Chi, Hyun-Sook
    Huh, Jooryung
    Suh, Cheolwon
    Shim, Hyoeun
    MEDICINE, 2018, 97 (45)
  • [8] Higher Response to Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Nongerminal Center B-Cell-Like Than in Germinal Center B-Cell-Like Phenotype
    Hernandez-Ilizaliturri, Francisco J.
    Deeb, George
    Zinzani, Pier L.
    Pileri, Stefano A.
    Malik, Farhana
    Macon, William R.
    Goy, Andre
    Witzig, Thomas E.
    Czuczman, Myron S.
    CANCER, 2011, 117 (22) : 5058 - 5066
  • [9] Prognostic value of immunohistochemical classification of diffuse large B-cell lymphoma into germinal center B-cell and non-germinal center B-cell subtypes
    Saad, Abeer A.
    Awed, Nahla M.
    Abdel-Hafeez, Zeinab M.
    Kamal, Gihan M.
    Elsallaly, Hala M.
    Alloub, Amal I.
    SAUDI MEDICAL JOURNAL, 2010, 31 (02) : 135 - 141
  • [10] Expression of programmed cell death ligand-1 protein in germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
    Asrini, Rizka
    Ham, Maria Francisca
    Asmarinah, Asmarinah
    Harahap, Agnes Stephanie
    Hardjolukito, Endang S. R.
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (02)
12345